Short-Lived Antibody-Mediated Saliva Immunity against SARS-CoV-2 after Vaccination
Open Access
- 13 April 2023
- journal article
- research article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (2) , e0494722
Abstract
Knowledge about the persistence of salivary immunity after SARS-CoV-2 vaccination is limited, and information on this topic could prove important for vaccine strategy and development. We hypothesized that salivary immunity would wane rapidly after vaccination.Keywords
Funding Information
- Carlsbergfondet (CF20-476 0045)
- Novo Nordisk Fonden (NFF205A0063505)
- Novo Nordisk Fonden (NNF20SA0064201)
- Svend Andersen Fonden (SARF2021)
This publication has 33 references indexed in Scilit:
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal modelsCell Host & Microbe, 2021
- SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent IndividualsThe Journal of Immunology, 2021
- Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 InfectionFrontiers in Immunology, 2020
- Salivary anti-SARS-CoV-2 IgA as an accessible biomarker of mucosal immunity against COVID-19medRxiv, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Exploiting Mucosal Immunity for Antiviral VaccinesAnnual Review of Immunology, 2016
- Regulation of the polymeric immunoglobulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mucosal immunityMucosal Immunology, 2011
- PASSAGE OF IMMUNOGLOBULINS FROM PLASMA TO ORAL CAVITY IN RHESUS-MONKEYS1978
- Immunoglobulins and complement in crevicular fluid, serum and saliva in manArchives of Oral Biology, 1972